Article
Genotype and dose-frequency determine acute and chronic effects of oxytocin on amygdala fear responses in humans: therapeutic implications
2018-12-11
Abstract excerpt
<h4>Background</h4> There is considerable interest in therapeutic application of intranasal oxytocin in psychiatric disorders, but while clinical trials typically use daily dosing protocols it has not been established whether this is optimal or if there are moderating influences of oxytocin receptor genotype. <h4>Methods</h4> In a randomized, placebo-controlled pre-registered trial on 138 adult male subjects we...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fb0c2194-fc32-5f84-8e38-337d24c37cd3
- DOI
- 10.1101/493387